World's Best Scientists 2026 revealed!
Award Badge
Medicine
Canada
2023

D-Index & Metrics

Discipline name D-Index World Ranking National Ranking Publications Citations
Medicine 142 1537 49 980 98605

Brian G. Feagan publications per year

The chart shows the history of publications by Brian G. Feagan between 1991 and 2025, highlighting the no. of papers published in each year and offering an overview of the publication velocity of this scholar. Brian G. Feagan published across 35 years, from 1991 to 2025, averaging 36.3 papers a year. Output peaked at 97 publications in 2017. 134 of the 1,269 publications appeared in the last two years.

No. of publications
20 40 60 80
Bar chart. Horizontal axis: year, 1991 to 2025. Vertical axis: number of publications, 0 to 97. Peak 97 publications in 2017. 1991: 1 publication 1992: 0 publications 1993: 2 publications 1994: 3 publications 1995: 3 publications 1996: 2 publications 1997: 8 publications 1998: 2 publications 1999: 5 publications 2000: 23 publications 2001: 11 publications 2002: 8 publications 2003: 10 publications 2004: 13 publications 2005: 14 publications 2006: 15 publications 2007: 28 publications 2008: 54 publications 2009: 22 publications 2010: 18 publications 2011: 29 publications 2012: 46 publications 2013: 51 publications 2014: 76 publications 2015: 61 publications 2016: 68 publications 2017: 97 publications 2018: 75 publications 2019: 90 publications 2020: 63 publications 2021: 82 publications 2022: 71 publications 2023: 84 publications 2024: 82 publications 2025: 52 publications
1991 2025

1,269 publications in total across all disciplines

View publications per year as a table
Brian G. Feagan: publications per year, 1991 to 2025
Year Publications
1991 1
1992 0
1993 2
1994 3
1995 3
1996 2
1997 8
1998 2
1999 5
2000 23
2001 11
2002 8
2003 10
2004 13
2005 14
2006 15
2007 28
2008 54
2009 22
2010 18
2011 29
2012 46
2013 51
2014 76
2015 61
2016 68
2017 97
2018 75
2019 90
2020 63
2021 82
2022 71
2023 84
2024 82
2025 52
Total 1,269
Download as CSV

Brian G. Feagan publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Brian G. Feagan sits on this spectrum.

No. of scientists
200 400 600 800
Bar chart with 86 bars. Horizontal axis: publications, 101–120 to 1,796+. Vertical axis: number of scientists, 0 to 922. Most scientists, 922, have 341–360 publications. The last bar groups every scientist with 1,796 publications or more. The highlighted bar, 961–980 publications, is where this scientist sits. 101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 610 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101–120 publications 1,796+

This scientist: 980 publications — 94th percentile

94% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

View publications distribution as a table
Number of Medicine scientists by publication count, Research.com 2026 ranking edition. Based on 20,134 ranked scientists.
Publications Scientists This scientist
101–120 5
121–140 26
141–160 73
161–180 155
181–200 230
201–220 363
221–240 487
241–260 545
261–280 722
281–300 768
301–320 834
321–340 895
341–360 922
361–380 838
381–400 861
401–420 918
421–440 806
441–460 771
461–480 751
481–500 713
501–520 617
521–540 610
541–560 537
561–580 504
581–600 509
601–620 396
621–640 386
641–660 371
661–680 340
681–700 336
701–720 307
721–740 259
741–760 230
761–780 228
781–800 217
801–820 204
821–840 186
841–860 177
861–880 155
881–900 139
901–920 145
921–940 116
941–960 133
961–980 91 980
981–1,000 96
1,001–1,020 77
1,021–1,040 70
1,041–1,060 63
1,061–1,080 77
1,081–1,100 49
1,101–1,120 54
1,121–1,140 49
1,141–1,160 51
1,161–1,180 35
1,181–1,200 39
1,201–1,220 26
1,221–1,240 37
1,241–1,260 36
1,261–1,280 27
1,281–1,300 32
1,301–1,320 28
1,321–1,340 17
1,341–1,360 30
1,361–1,380 28
1,381–1,400 17
1,401–1,420 21
1,421–1,440 15
1,441–1,460 12
1,461–1,480 12
1,481–1,500 18
1,501–1,520 14
1,521–1,540 17
1,541–1,560 15
1,561–1,580 6
1,581–1,600 2
1,601–1,620 12
1,621–1,640 11
1,641–1,660 8
1,661–1,680 5
1,681–1,700 5
1,701–1,720 10
1,721–1,740 12
1,741–1,760 14
1,761–1,780 6
1,781–1,795 5
1,796+ 100
Download as CSV

Brian G. Feagan D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Brian G. Feagan sits on this spectrum.

No. of scientists
250 500 750 1,000
Bar chart with 75 bars. Horizontal axis: D-Index, 70–71 to 217+. Vertical axis: number of scientists, 0 to 1,027. Most scientists, 1,027, have 82–83 D-Index. The last bar groups every scientist with 217 D-Index or more. The highlighted bar, 142–143 D-Index, is where this scientist sits. 70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 399 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70–71 D-Index 217+

This scientist: 142 D-Index — 92nd percentile

92% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

View D-Index distribution as a table
Number of Medicine scientists by D-index, Research.com 2026 ranking edition. Based on 20,134 ranked scientists.
D-Index Scientists This scientist
70–71 226
72–73 391
74–75 574
76–77 730
78–79 891
80–81 972
82–83 1,027
84–85 1,003
86–87 960
88–89 970
90–91 922
92–93 839
94–95 808
96–97 779
98–99 668
100–101 611
102–103 630
104–105 513
106–107 541
108–109 445
110–111 429
112–113 399
114–115 393
116–117 318
118–119 302
120–121 287
122–123 255
124–125 256
126–127 252
128–129 230
130–131 179
132–133 168
134–135 163
136–137 159
138–139 134
140–141 134
142–143 118 142
144–145 109
146–147 106
148–149 74
150–151 79
152–153 80
154–155 87
156–157 57
158–159 74
160–161 69
162–163 60
164–165 53
166–167 39
168–169 42
170–171 32
172–173 39
174–175 40
176–177 28
178–179 19
180–181 23
182–183 31
184–185 18
186–187 20
188–189 22
190–191 13
192–193 21
194–195 12
196–197 12
198–199 14
200–201 15
202–203 13
204–205 10
206–207 8
208–209 4
210–211 12
212–213 11
214–215 10
216 4
217+ 98
Download as CSV

Research.com Recognitions

  • 2023 - Research.com Medicine in Canada Leader Award

Overview

Brian G. Feagan is a researcher affiliated with the University of Western Ontario in Canada. Their work is primarily situated in the fields of Medicine and Biochemistry, Genetics and Molecular Biology, with a strong focus on subfields such as Genetics, Epidemiology, Surgery, Immunology, and Oncology.

The main topics in their research include Inflammatory Bowel Disease, Microscopic Colitis, Eosinophilic Esophagitis, Autoimmune and Inflammatory Disorders, Immunodeficiency and Autoimmune Disorders, Helicobacter pylori-related gastroenterology studies, and Chronic Lymphocytic Leukemia Research.

The scientist has contributed to several notable publications, particularly in leading medical journals. Recent papers authored or co-authored by them include:

  • Filgotinib as induction and maintenance therapy for ulcerative colitis (SELECTION): a phase 2b/3 double-blind, randomised, placebo-controlled trial, 2021, The Lancet

Other influential papers from their field of work, though authored by frequent collaborators, include:

  • Ozanimod as Induction and Maintenance Therapy for Ulcerative Colitis, 2021, New England Journal of Medicine
  • Risankizumab as induction therapy for Crohn's disease: results from the phase 3 ADVANCE and MOTIVATE induction trials, 2022, The Lancet
  • Efficacy and Safety of Upadacitinib in a Randomized Trial of Patients With Crohn's Disease, 2020, Gastroenterology
  • Etrasimod as induction and maintenance therapy for ulcerative colitis (ELEVATE): two randomised, double-blind, placebo-controlled, phase 3 studies, 2023, The Lancet

They frequently collaborate with several other researchers in the gastroenterology and immunology fields. Notable co-authors include:

  • William J. Sandborn
  • Bruce E. Sands
  • Laurent Peyrin-Biroulet
  • Geert D'Haens
  • Silvio Danese

The scientist regularly publishes in leading journals relevant to their specialty, such as:

  • Gastroenterology
  • Journal of Crohn's and Colitis
  • The American Journal of Gastroenterology
  • Clinical Gastroenterology and Hepatology
  • Alimentary Pharmacology & Therapeutics

Best Publications

  • Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial

    Stephen B Hanauer;Brian G Feagan;Gary R Lichtenstein;Lloyd F Mayer

  • Infliximab for induction and maintenance therapy for ulcerative colitis.

    Paul Rutgeerts;William J Sandborn;Brian G Feagan;Walter Reinisch

  • Vedolizumab as induction and maintenance therapy for ulcerative colitis.

    Brian G Feagan;Paul Rutgeerts;Bruce E Sands;Stephen Hanauer

  • Infliximab Maintenance Therapy for Fistulizing Crohn's Disease

    Bruce E. Sands;Frank H. Anderson;Charles N. Bernstein;William Y. Chey

  • Vedolizumab as Induction and Maintenance Therapy for Crohn's Disease

    William J. Sandborn;Brian G. Feagan;Paul Rutgeerts;Stephen Hanauer

  • Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): Determining Therapeutic Goals for Treat-to-Target.

    L. Peyrin-Biroulet;W. Sandborn;B. E. Sands;W. Reinisch;W. Reinisch

  • Secukinumab, a human anti-IL-17A monoclonal antibody, for moderate to severe Crohn's disease: unexpected results of a randomised, double-blind placebo-controlled trial

    Wolfgang Hueber;Bruce E Sands;Steve Lewitzky;Marc Vandemeulebroecke

  • A review of activity indices and efficacy end points for clinical trials of medical therapy in adults with ulcerative colitis.

    Geert D’Haens;William J. Sandborn;Brian G. Feagan;Karel Geboes

  • Tofacitinib as Induction and Maintenance Therapy for Ulcerative Colitis

    William J. Sandborn;Chinyu Su;Bruce E. Sands;Geert R. D’Haens

  • Certolizumab pegol for the treatment of Crohn’s disease:

    William J. Sandborn;Brian G. Feagan;Simeon Stoinov;Pieter J. Honiball

  • Early combined immunosuppression or conventional management in patients with newly diagnosed Crohn's disease: an open randomised trial

    Geert D'Haens;Filip Baert;Gert van Assche;Philip Caenepeel

  • SCENIC international consensus statement on surveillance and management of dysplasia in inflammatory bowel disease

    Loren Laine;Loren Laine;Tonya Kaltenbach;Alan Barkun;Kenneth R. McQuaid

  • Ustekinumab Induction and Maintenance Therapy in Refractory Crohn's Disease

    William J. Sandborn;Christopher Gasink;Long Long Gao;Marion A. Blank

  • Comparison of scheduled and episodic treatment strategies of infliximab in Crohn's disease.

    Paul Rutgeerts;Brian G. Feagan;Gary R. Lichtenstein;Lloyd F. Mayer

  • Serious Infections and Mortality in Association With Therapies for Crohn’s Disease: TREAT Registry

    Gary R. Lichtenstein;Brian G. Feagan;Russell D. Cohen;Bruce A. Salzberg

  • Natalizumab induction and maintenance therapy for Crohn's disease.

    William J. Sandborn;Jean Frédéric Colombel;Roberts Enns;Brian G. Feagan

  • Treatment of ulcerative colitis with a humanized antibody to the alpha4beta7 integrin.

    Brian G Feagan;Gordon R Greenberg;Gary Wild;Richard N Fedorak

  • Early Mucosal Healing With Infliximab Is Associated With Improved Long-term Clinical Outcomes in Ulcerative Colitis

    Jean Frédéric Colombel;Paul Rutgeerts;Walter Reinisch;Dirk Esser

  • Subcutaneous golimumab induces clinical response and remission in patients with moderate-to-severe ulcerative colitis.

    William J Sandborn;Brian G Feagan;Colleen W Marano;Hongyan Zhang

  • A Controlled Trial of a Critical Pathway for Treatment of Community-Acquired Pneumonia

    Thomas J. Marrie;Catherine Y. Lau;Susan L. Wheeler;Cindy J. Wong

Frequent Co-Authors

William J. Sandborn
William J. Sandborn University of California, San Diego
Jean-Frederic Colombel
Jean-Frederic Colombel Icahn School of Medicine at Mount Sinai
Bruce E. Sands
Bruce E. Sands Icahn School of Medicine at Mount Sinai
Geert R. D'Haens
Geert R. D'Haens University of Amsterdam
Walter Reinisch
Walter Reinisch Medical University of Vienna
Stephen B. Hanauer
Stephen B. Hanauer Northwestern University
Remo Panaccione
Remo Panaccione University of Calgary
Stefan Schreiber
Stefan Schreiber Kiel University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Aspiring medical professionals have more flexible education options than ever before, thanks to online degree programs in key healthcare fields. For those interested in nursing, several affordable pathways exist, each catering to a variety of backgrounds and career aspirations.

Current registered nurses can pursue advanced academic roles by enrolling in doctorate in nursing education online programs to prepare for teaching, research, or leadership careers. If you’re looking to enhance your nursing credentials without a large financial burden, check out the cheapest rn to bsn online programs.

For those considering a career pivot, there are online msn programs for non nurses that allow individuals from non-nursing backgrounds to quickly transition into nursing at an advanced level. Alternatively, individuals without prior nursing experience can start their journey with online adn programs for non nurses, providing a foundational entry point into the healthcare field.

With these diverse and accessible online options, students can find a program that matches their needs—whether aiming for clinical practice, education, or administration in medicine and healthcare.

Best Scientists Citing Brian G. Feagan

Trending Scientists

Recently Published Articles